IPIX is in the negotiating phase before inking a mutually beneficial deal. Not saying it'll be easy, and there will no doubt be some give and take. But it'll get done, in my opinion. OM and IBD together is the sweet spot for tapping into hugely profitable markets with innovative treatments proven to be effective in clinical trials. I'll sleep will and be patient until the signed deal is announced.
News 
Market Data 
Discover 
AI
